Clinical Trial Update: Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA) [NA]

View source ↗

Summary

The GINEBRA clinical trial is evaluating the effects of glucose-dependent insulinotropic polypeptide (GIP) on bone remodeling and cellular activity in participa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Bone Disease
• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• glucose-dependent insulinotropic polypeptide (GIP) (glucose-dependent insulinotropic polypeptide)

Snippet

Sponsor: Esbjerg Hospital - University Hospital of Southern Denmark | Conditions: Bone Disease, Metabolic, Diabetes Mellitus, Type 2 | NA | Status: RECRUITING